Replies to post #159 on Adaptimmune Therapeutics PLC (ADAP)

[jondoeuk]

''Next week, we will post the replay of the virtual update about our allogeneic programs. During the update, we shared our allo pipeline & the news that we we intend to file an IND for our first allo TCR against MAGE-A4 in late 2023. Click on the image to find the presentation.''

Next week, we will post the replay of the virtual update about our allogeneic programs. During the update, we shared our allo pipeline & the news that we we intend to file an IND for our first allo TCR against MAGE‑A4 in late 2023. Click on the image to find the presentation.

— Adaptimmune (@Adaptimmune) September 10, 2021